A Phase II Trial of JM-216 in Cervical Cancer: An NCIC CTG Study

Author： Trudeau M.   Stuart G.   Hirte H.   Drouin P.   Plante M.   Bessette P.   Dulude H.   Lebwohl D.   Fisher B.   Seymour L.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.84, Iss.2, 2002-02, pp. : 327-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial

By O’Malley F.   Chia S.   Tu D.   Shepherd L.   Levine M.   Huntsman D.   Bramwell V.   Andrulis I.   Pritchard K.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 401-409

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

By Lhomme C.   Vermorken J.B.   Mickiewicz E.   Chevalier B.   Alvarez A.   Mendiola C.   Pawinski A.   Lentz M.A.   Pecorelli S.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 194-199

Elsevier

Access to resources Recommend Favorite

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19

By Liu Jianhua   Tu Dongsheng   Dancey Janet   Reyno Leonard   Pritchard Kathleen I.   Pater Joseph   Seymour Lesley K  

Breast Cancer Research and Treatment, Vol. 100, Iss. 3, 2006-12 ,pp. : 263-271

Springer Publishing Company

Access to resources Recommend Favorite

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

By Vickers M. M.   Karapetis C. S.   Tu D.   O'Callaghan C. J.   Price T. J.   Tebbutt N. C.   Van Hazel G.   Shapiro J. D.   Pavlakis N.   Gibbs P.   Blondal J.   Lee U.   Meharchand J. M.   Burkes R. L.   Rubin S. H.   Simes J.   Zalcberg J. R.   Moore M. J.   Zhu L.   Jonker D. J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 953-960

Oxford University Press

Access to resources Recommend Favorite